RAPT Therapeutics shows strong pipeline progress with ozureprubart, favorable Phase 2 data, $250M cash, and high-risk market ...

Lexicon Pharmaceuticals targets a turnaround with sotagliflozin, LX9851, pilavapadin, and partnerships offering multiple ...

Merck & Co. has agreed to acquire Cidara Therapeutics for approximately $9.2 billion, the companies said, in a deal designed to bolster the buyer’s antiviral portfolio with a Phase III drug designed ...

Viking Therapeutics shares have delivered explosive gains this week, climbing to their highest level in ten months. The ...